Levocet M Kid Tablet MD is a combination medication containing Levocetirizine 2.5 mg and Montelukast 4 mg, formulated specifically for pediatric use. Levocetirizine is a second-generation antihistamine that selectively inhibits peripheral H1 receptors, thereby reducing symptoms associated with allergic rhinitis and chronic urticaria such as sneezing, nasal congestion, itching, and hives. Montelukast is a leukotriene receptor antagonist that blocks the action of leukotrienes, inflammatory mediators involved in asthma and allergic rhinitis, helping to prevent bronchoconstriction, inflammation, and mucus production. The combined action of these two agents provides comprehensive relief from allergic symptoms and helps in the management of asthma in children. Levocet M Kid Tablet MD is indicated for the treatment of allergic rhinitis, chronic idiopathic urticaria, and as an adjunct therapy for asthma control in pediatric patients. It is generally well-tolerated, with a low incidence of sedation compared to first-generation antihistamines. Dosage should be as prescribed by a healthcare professional, considering the child’s age and clinical condition. Caution is advised in patients with hepatic or renal impairment, and potential drug interactions should be reviewed prior to initiation.